Physician

Rajeev Narang, M.D.

According to 2025 Medicare claims, Rajeev Narang, M.D. (NPI: 1700894359) practices pulmonary disease in the Corpus Christi, TX market, with the plurality of this provider's patient population coming from Nueces, TX. This provider's primary affiliated billing organization is SOUTH TEXAS PULMONARY AND CRITICAL CARE ASSOCIATES (NPI: 1639113368; TIN: 742786892) and primary practice location at 78404-3109.

Narang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 873 traditional Medicare patients, billed 5,317 HCPCS/CPT codes, and received $407,544 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,495 prescription claims across 1,084 beneficiaries totaling $3,076,723 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 3,131 claims. Open Payments data shows 128 records totaling $10,942. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $784,172 to $3,076,723. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $119,881 to $178,218.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	842	6,898	$495,088
2016	984	6,230	$444,032
2017	1,155	7,006	$523,714
2018	1,294	8,346	$585,375
2019	1,270	7,568	$532,307
2020	1,291	8,140	$629,615
2021	1,059	6,799	$514,767
2022	966	6,057	$448,183
2023	902	4,889	$358,859
2024	873	5,317	$407,544

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	596	4,509	$784,172
2016	711	4,815	$1,042,575
2017	973	6,409	$1,559,675
2018	1,204	7,731	$2,102,970
2019	1,024	6,330	$2,556,296
2020	1,000	6,110	$2,577,374
2021	951	4,838	$2,108,234
2022	868	4,377	$1,843,130
2023	901	4,748	$2,356,300
2024	1,084	5,495	$3,076,723

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	603	2,067	$135,518
2016	694	2,227	$92,373
2017	925	2,624	$77,438
2018	1,243	3,810	$140,566
2019	1,467	5,087	$198,689
2020	1,511	4,701	$225,975
2021	1,390	4,228	$198,220
2022	1,280	3,635	$213,195
2023	1,183	3,512	$246,056
2024	1,074	3,131	$164,790

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	349	759	$93
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	297	1,209	$59
94729	Test to examine how well the lungs exchange gases	268	270	$37
94060	Test to measure expiratory airflow and volume changes before and after medication administration	270	272	$27
94664	Evaluation of use of breathing device	313	530	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	593	31,300	$663,023
Ofev	Nintedanib Esylate	29	1,155	$497,435
Tyvaso Dpi	Treprostinil	12	336	$308,084
Aralast Np	Alpha-1-Proteinase Inhibitor	13	364	$209,661
Opsumit	Macitentan	11	330	$140,974

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	49	339	$28,937
A7031	Face mask interface, replacement for full face mask, each	N	75	210	$19,729
A7030	Full face mask used with positive airway pressure device, each	N	79	200	$18,653
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	15	$15,128
E0601	Continuous positive airway pressure (cpap) device	Y	59	265	$10,633

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	128	$10,942	INTUITIVE SURGICAL, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajeev Narang, M.D.?

Tedicare shows public-source Medicare data for Rajeev Narang, M.D. (NPI 1700894359), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajeev Narang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rajeev Narang, M.D.?

Rajeev Narang, M.D. is linked to SOUTH TEXAS PULMONARY AND CRITICAL CARE ASSOCIATES (billing NPI 1639113368) in the available physician profile data.

Does Rajeev Narang, M.D. have Open Payments data?

Rajeev Narang, M.D. has 128 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.